Physician

Aaron Provenzano

According to 2025 Medicare claims, Aaron Provenzano (NPI: 1376715284) practices medical oncology in the Weirton-Steubenville, WV-OH market, with the plurality of this provider's patient population coming from Jefferson, OH. This provider's primary affiliated billing organization is ONCOLOGY HEMATOLOGY ASSOCIATION INC (NPI: 1861469223; TIN: 251762980) and primary practice location at 43952-2300. Provenzano is affiliated with the IHC Quality Partners, LLC (ACO ID: A2833) and ACO West Virginia (ACO ID: A3563), participating under the MSSP model.

Provenzano's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 442 traditional Medicare patients, billed 1,267 HCPCS/CPT codes, and received $88,064 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,148 prescription claims across 288 beneficiaries totaling $2,105,025 in drug costs, led by Koselugo (Selumetinib Sulfate). DME data shows 64 claims. Open Payments data shows 24 records totaling $577. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $56,884 to $88,064. Similarly, Part D prescription costs have risen steadily, from $15,302 to $2,105,025. In contrast, DME billing represents a smaller volume and declined steadily, from $7,374 to $164.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	288	723	$56,884
2016	165	392	$27,330
2017	195	542	$33,823
2018	223	585	$37,070
2019	255	1,223	$92,724
2020	213	939	$64,917
2021	321	1,043	$89,322
2022	350	962	$78,770
2023	408	1,033	$86,438
2024	442	1,267	$88,064

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	129	339	$15,302
2016	29	125	$51,846
2017	43	274	$127,193
2018	52	265	$41,378
2019	100	440	$458,565
2020	126	782	$923,202
2021	194	1,154	$1,882,821
2022	234	1,215	$2,195,934
2023	304	1,352	$2,220,915
2024	288	1,148	$2,105,025

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	86	$7,007
2016	N/R	50	$2,624
2017	N/R	96	$13,694
2018	N/R	40	$6,102
2019	N/R	N/R	N/R
2020	N/R	24	$1,222
2021	N/R	125	$8,421
2022	N/R	167	$6,146
2023	11	79	$13,025
2024	N/R	64	$1,373

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	101	278	$104
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	51	51	$100
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	259	413	$68
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	99	112	$45
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	161	209	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Koselugo	Selumetinib Sulfate	12	360	$335,235
Xtandi	Enzalutamide	20	600	$281,106
Calquence	Acalabrutinib Maleate	23	690	$260,973
Ibrance	Palbociclib	21	588	$217,326
Abiraterone Acetate	Abiraterone Acetate	23	654	$114,184

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	12	$550
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	28	$351
J8999	Prescription drug, oral, chemotherapeutic, nos	N	N/R	12	$246
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	12	$226

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	24	$577	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aaron Provenzano?

Tedicare shows public-source Medicare data for Aaron Provenzano (NPI 1376715284), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Provenzano have ACO affiliation data?

Aaron Provenzano is shown with ACO affiliation data for IHC Quality Partners, LLC (MSSP, ACO ID A2833) and ACO West Virginia (MSSP, ACO ID A3563).

What billing organization is linked to Aaron Provenzano?

Aaron Provenzano is linked to ONCOLOGY HEMATOLOGY ASSOCIATION INC (billing NPI 1861469223) in the available physician profile data.

Does Aaron Provenzano have Open Payments data?

Aaron Provenzano has 24 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.